Shell Pharmaceuticals Private Limited, a active private limited company, was established on 05 August 2009 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2009PTC449217. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Srinivasa Ramanathan Manickam (Director), Darshan Anil Haria (Additional Director), Harshal Ashok Chaudhari (Director). Past directors included Milind Pattarkine, Srinivasa Ramanathan Manickam, Gnanam Muthuraman. It holds ₹35.00 Cr open charges and ₹51.45 Cr settled loans. Its latest AGM occurred on 03 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-3 And B 7, 1St Flr, Krishna Mill Compound, Sonapur Lane Lbs Marg, Mumbai, Maharashtra, 400078.
U51909MH2009PTC449217
449217
05 August 2009
₹1.00 M
₹0.90 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Ramanathan Manickam | Director | 27 Feb 2023 | Current |
| Darshan Anil Haria | Additional Director | 01 Apr 2025 | Current |
| Harshal Ashok Chaudhari | Director | 20 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 19 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Managing Director | 19 Jun 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Shell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹350,000,000.00
₹514,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2019 | Axis Bank Limited | ₹35.00 Cr | Satisfied |
| 21 Nov 2017 | Others | ₹7.20 Cr | Satisfied |
| 11 Jul 2017 | Hdfc Bank Limited | ₹4.50 Cr | Satisfied |
| 01 Mar 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.75 Cr | Satisfied |
| 16 Feb 2015 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shell Pharmaceuticals Private Limited last Annual general meeting of members was held on 03 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Harshal Ashok Chaudhari was appointed as a Director was appointed as a Director on 20 Aug 2025 & has been associated with this company since 3 months 9 days . was completed.
The activity Darshan Anil Haria was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 7 months 28 days . was completed.
Shell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge registered on 09 Oct 2019 via Charge ID 100298101 with Axis Bank Limited was fully satisfied on 18 Mar 2025. was completed.
The activity Srinivasa Ramanathan Manickam was appointed as a Director was appointed as a Director on 27 Feb 2023 & has been associated with this company since 2 years 9 months . was completed.
The CIN of Shell Pharmaceuticals Private Limited is U51909MH2009PTC449217.
Shell Pharmaceuticals Private Limited is headquartered at B-3 And B 7, 1St Flr, Krishna Mill Compound, Sonapur Lane Lbs Marg, Mumbai, Maharashtra, 400078.
Shell Pharmaceuticals Private Limited was incorporated on 05 August 2009.
The current directors of Shell Pharmaceuticals Private Limited are
The primary industry of Shell Pharmaceuticals Private Limited is Trade.
Shell Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shell Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.90 M.
The compliance status of Shell Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX